Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2005
12/29/2005US20050287163 Mycoplasma polypeptides
12/29/2005US20050287157 Dry formulation for transcutaneous immunization
12/29/2005US20050287141 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2005DE60202483T2 Verfahren zur herstellung von l-ribavirin A process for the preparation of L-Ribavirin
12/29/2005DE10228059B4 Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases
12/29/2005CA2571501A1 Antimicrobial compositions and methods of use thereof
12/29/2005CA2570508A1 Preparation of protective antigen from bacillus anthracis
12/29/2005CA2570158A1 Potent and selective inhibition by aurintricarboxylic acid
12/29/2005CA2569729A1 Peptidomimetic inhibitors of retroviral proteases and their use as antivirals
12/29/2005CA2569116A1 Gram-positive carbapenem antibacterials and processes for their preparation
12/29/2005CA2568907A1 8-carbyl substituted cyclic adenosine-3'-5'-monophosphorothiolate compounds as camp modulators
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609476A1 Composition for treating hepatitis c
12/28/2005EP1609473A1 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria
12/28/2005EP1609467A1 Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
12/28/2005EP1608757A1 Modified beta-lactamases and uses thereof
12/28/2005EP1608661A2 Process for the preparaton of 7-(p-hydroxyphenylglycylamido)cephem compounds
12/28/2005EP1608633A1 Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases
12/28/2005EP1608629A1 Benzyl-pyridazinons as reverse transcriptase inhibitors
12/28/2005EP1608402A1 Improved vaccines
12/28/2005EP1608401A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune respones
12/28/2005EP1608377A2 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
12/28/2005EP1608369A2 Use of organic compounds for immunopotentiation
12/28/2005EP1608312A2 Methods for obtaining colonization factors from bacterial strains
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1434779B1 Cross-linked glycopeptide-cephalosporin antibiotics
12/28/2005EP1399416A4 Peptide deformylase inhibitors
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1373241B1 Method for producing optically active dihydropyrones
12/28/2005EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/28/2005EP1257276B1 Antiviral azaindole derivatives
12/28/2005EP1254131B8 Extraction of flavonoids
12/28/2005EP1246627B1 Polyanhydrides with biologically active degradation products
12/28/2005EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP1123114B1 Virus-like particles for the induction of autoantibodies
12/28/2005EP0953642B1 Antigenic protein originating in infectious laryngotracheitis virus
12/28/2005EP0879281B1 Methods for transforming dendritic cells and activating t cells
12/28/2005EP0876387B1 Use of roxithromycin for the preparation of a medicament for improving the biological and antiviral activity of protease inhibitors
12/28/2005EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides
12/28/2005EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
12/28/2005EP0705103B1 Use of notoginsenoside r1 for the treatment of endotoxin shock or heart diseases
12/28/2005CN1714148A Viral deconstruction through capsid assembly in vitro
12/28/2005CN1714100A Antigen peptides
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714091A Meso-substituted porphyrins
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713895A Increased-dosage nelfinavir tablet and method of making same
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233403C Medicine for preventing and treating infectious coryza
12/28/2005CN1233401C Agastache capsule for restoring healthy energy and its preparation
12/28/2005CN1233400C Fever bringing down formulation for preventing virus and its prepn. method
12/28/2005CN1233399C Effervescence tablet of radix isatidis and its preparation
12/28/2005CN1233397C Shuanghuanglian effervescence tablet and its preparation
12/28/2005CN1233388C Medicinal composition for treating hepatitis
12/28/2005CN1233367C Inflammation diminishing and granulation promoting medicine powder
12/28/2005CN1233362C Flu and prostatitis preventing and curing medicine, and method for making same
12/28/2005CN1233358C Method for extracting substance resisting respiratory syncytial virus from patrinia
12/28/2005CN1233357C Insect-ant capsule
12/28/2005CN1233318C Hepadestal soft capsule and its preparing method
12/28/2005CN1233317C Milk thistle silybum marianum self-emulsified micro-emulsion composition and its preparation process
12/28/2005CN1233312C Liposome anti-fungus medication sprayer formulation
12/28/2005CN1233311C Compound ointment for treating fungous dermatosis
12/28/2005CN1233257C A composition containing carvacrol and thymol for use as abactericide
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979449 Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis
12/27/2005US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/27/2005CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv
12/27/2005CA2337509C Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/27/2005CA2137280C Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
12/22/2005WO2005121342A1 Recombinant enterotoxin c and vaccine with the use of the same
12/22/2005WO2005121172A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/22/2005WO2005121170A1 Abc transporter protein that confers resistance to bacitracin in interococci
12/22/2005WO2005121132A1 Fused heterocyclic compound having anti-hcv effect
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005120577A2 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity
12/22/2005WO2005120556A1 Human lysozyme medicine, its manufacturing method and application thereof
12/22/2005WO2005120555A1 Use of human lysozyme in preparation of medicine for treating acne
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2005058231A3 Rifamycin analogs and uses thereof
12/22/2005WO2005023290A3 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282895 Antimicrobial compositions and methods of use thereof
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282842 Therapeutic compounds based on pyrazolopyridine derivatives
12/22/2005US20050282837 for use as anticancer agents and in treatment of herpes virus; packs/kits for plaque reduction
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050281847 Vaccine composition
12/22/2005US20050281843 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
12/22/2005US20050281834 Altered peptide ligands
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 1798